Quantcast
Home > Quotes > XBIOW

Xenetic Biosciences, Inc. Warrants (XBIOW) Quote & Summary Data

XBIOW 
$1.75
*  
0.45
34.62%
Get XBIOW Alerts
*Delayed - data as of Aug. 16, 2019  -  Find a broker to begin trading XBIOW now
Exchange:NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Key Stock Data

Best Bid / Ask
N/A / N/A
1 Year Target
Today's High / Low
$ 1.75 / $ 1.50
Share Volume
1,228
50 Day Avg. Daily Volume
N/A
Previous Close
$ 1.30
52 Week High / Low
$ 2.31 / $ 1.30
Market Cap
Annualized Dividend
N/A
Ex Dividend Date
N/A
Dividend Payment Date
N/A
Current Yield
0 %
Beta
0

Intraday Chart

Shares Traded

Share Volume:
1,228
50 Day Avg. Daily Volume:
N/A

Trading Range

The current last sale of $1.75 is 34.62% Higher than the 52 week low.

Intraday Last 52 Weeks
High: $ 1.75 $ 2.31
 Low: $ 1.50 $ 1.30

Company Description (as filed with the SEC)

We are a biopharmaceutical company focused on the discovery, research and development of next-generation biological drugs and novel oncology therapeutics. We have an extensive patent portfolio of over 170 issued patents in the U.S. and worldwide, covering various aspects of our PolyXen(TM) platform technology and advanced polymer conjugate technologies, as well as our proprietary biologic drugs and novel oncology drug candidates. We believe our portfolio positions us well for strategic partnership and commercialization opportunities. Our objective is to leverage our portfolio to maximize opportunities to out-license assets from our portfolio in order to generate working capital to both build long-term stockholder value and provide us with the funding necessary for clinical development of our oncology drug candidates through market launch.  ... More ...  

Nasdaq Official Price

Open Price:
N/A
Open Date:
N/A
Close Price:
N/A
Close Date:
N/A


Research Brokers before you trade

Want to trade FX?

Analyst Info